...label in China for Junshi’s PD-1 mAbShanghai Junshi Biosciences Co. Ltd. (HKEX:1877; Shanghai:688180) said China’s National Medical Products Administration...

...study. On March 22, CanSino said China’s National Medical Products Administration...

...treat focal onset seizures.Zai gains China approval of QinlockZai Lab Ltd. (NASDAQ:ZLAB; HKEX:9688) said China’s National Medical Products Administration...

...the targeted radioligand therapy candidate.CStone lands China nod for GavretoCStone Pharmaceuticals Co. Ltd (HKEX:2616) said China’s National Medical Products Administration...

...million in milestones per program, plus tiered royalties. A first for Everest Everest Medicines Ltd. said China’s National Medical Products Administration...

...By Paul Bonanos, Associate Editor CanSino Biologics Inc. (HKEX:6185) said China’s National Medical Products Administration is reviewing its application...

...Huntingtin (HTT) gene.China’s NMPA clears use of Astellas’ XospataXospata gilteritinib gained conditional approval from China’s National Medical Products Administration...

...study on the advice of a safety review board.Approval in China for AstraZeneca, Innovent drugsChina’s National Medical Products Administration...

...regimens. Sinovac seeking conditional authorization of vaccine in ChinaSinovac Biotech Ltd. (NASDAQ:SVA) submitted an application to China’s National Medical Products Administration...

...treat HER2-positive metastatic breast cancer. EdiGene’s CRISPR therapy for β thalassemia moves into clinicEdiGene Inc. said China’s National Medical Products Administration...